Home
/
BIOLIFE SOLUTIONS INC
/
Financials
/
Quarterly
BIOLIFE SOLUTIONS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOLIFE SOLUTIONS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2014
Sep 30, 2014
$1.24M
Nov 6, 2014
Q2
2014
Jun 30, 2014
$1.21M
Aug 7, 2014
Q1
2014
Mar 31, 2014
$2.07M
May 8, 2014
Q3
2014
Sep 30, 2013
$2.17M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$2.33M
Aug 7, 2014
Q1
2014
Mar 31, 2013
$2.16M
May 8, 2014
Q3
2013
Sep 30, 2012
$1.68M
Nov 14, 2013
Q2
2013
Jun 30, 2012
$1.10M
Aug 12, 2013
Q1
2013
Mar 31, 2012
$835.9K
May 14, 2013
Q3
2012
Sep 30, 2011
$715.5K
Nov 13, 2012
Q2
2012
Jun 30, 2011
$622.8K
Aug 14, 2012
Q1
2012
Mar 31, 2011
$610.8K
May 14, 2012
Q3
2011
Sep 30, 2010
$524.9K
Nov 14, 2011
Q2
2011
Jun 30, 2010
$467.8K
Aug 12, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$621.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
($15.84M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($448.0K)
May 8, 2025
Q3
2025
Sep 30, 2024
($1.70M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($20.72M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($10.22M)
May 8, 2025
Q3
2024
Sep 30, 2023
($29.13M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($10.20M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($13.71M)
May 10, 2024
Q3
2023
Sep 30, 2022
($10.32M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($72.88M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($7.42M)
May 11, 2023
Q3
2022
Sep 30, 2021
$79.0K
Nov 9, 2022
Q2
2022
Jun 30, 2021
$7.88M
Aug 9, 2022
Q1
2022
Mar 31, 2021
($1.12M)
May 10, 2022
Q3
2021
Sep 30, 2020
($1.13M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($16.38M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
$22.31M
May 17, 2021
Q3
2020
Sep 30, 2019
$10.27M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$4.25M
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($89.0K)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($16.64M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($1.22M)
May 8, 2025
Q3
2025
Sep 30, 2024
($418.0K)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($1.31M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($3.30M)
May 8, 2025
Q3
2024
Sep 30, 2023
($15.48M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($10.63M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($13.61M)
May 10, 2024
Q3
2023
Sep 30, 2022
($11.74M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($76.56M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($7.97M)
May 11, 2023
Q3
2022
Sep 30, 2021
($11.16M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($4.56M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($981.0K)
May 10, 2022
Q3
2021
Sep 30, 2020
($1.25M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
$44.0K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$370.0K
May 17, 2021
Q3
2020
Sep 30, 2019
($772.0K)
Nov 9, 2020
Q2
2020
Jun 30, 2019
$747.0K
Aug 10, 2020